Company Spherix Inc Nasdaq

Equities

US84842R4039

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Other Biotechnology & Medical Research

Inactive Instrument

Dominari Holdings Inc. is a holding company. The Company, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading and asset management. It operates through its wholly owned subsidiaries, including Dominari Financial Inc. (Dominari Financial) and Dominari Securities LLC (Dominari Securities). Dominari Securities offers and plans to offer a range of broker-dealer and registered investment adviser services. Its services include wealth management, investment banking, sales and trading, asset management and insurance products. Dominari Securities provides a comprehensive array of financial services to high-net-worth individuals and families, corporate executives, and public and private businesses. Dominari Securities also provides full-service brokerage, wealth planning and margin lending services. Dominari Securitiesâ investment banking division provides strategic advisory services and capital markets products to middle market businesses.

USD in Million	2022	Weight	2023	Weight	Delta
Dominari Financial 100.0 %	-	-	2	100.0 %	-

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	0	nan %	2	100.0 %	-

Managers	Title	Age	Since
Anthony Hayes CEO	Chief Executive Officer	56	13-02-28
Kyle Wool PSD	President	-	21-04-11
George M. Way DFI	Director of Finance/CFO	-	23-04-02
Christopher Devall COO	Chief Operating Officer	-	22-06-30
Matthew McCullough LAW	General Counsel	-	23-04-30
Darrell Dotson LAW	General Counsel	-	-

Members of the board	Title	Age	Since
Tim Ledwick BRD	Director/Board Member	66	15-07-08
Anthony Hayes CEO	Chief Executive Officer	56	13-02-28
Gregory Blattner BRD	Director/Board Member	47	18-05-02
Robert Dudley BRD	Director/Board Member	70	20-04-16
Kyle Wool PSD	President	-	21-04-11
Soo Yu BRD	Director/Board Member	53	22-06-06
Kyle Haug BRD	Director/Board Member	41	11-08

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	3,825	0	0	67.25 %
Stock B	0	834	0	0
Stock C	1	5,995,065	4,035,050 ( 67.31 %)	60,148 ( 1.003 %)

Name	Equities	%	Valuation
Soo Yu 21.18 %	1,257,216	21.18 %	3 M $
Anthony Hayes 5.719 %	339,394	5.719 %	750 061 $
Kyle Wool 4.468 %	265,181	4.468 %	586 050 $
Vanguard Group, Inc. (Subfiler) 3.259 %	193,392	3.259 %	427 396 $
George M. Way 1.623 %	96,311	1.623 %	212 847 $
BlackRock Institutional Trust Co. NA 1.222 %	72,519	1.222 %	160 267 $
Renaissance Technologies LLC 0.7233 %	42,926	0.7233 %	94 866 $
Geode Capital Management LLC 0.6610 %	39,229	0.6610 %	86 696 $
Dimensional Fund Advisors LP 0.6298 %	37,376	0.6298 %	82 601 $
Christopher Devall 0.5060 %	30,033	0.5060 %	66 373 $

Name	Equities	%	Valuation
Daniel W Armstrong 28.57 %	1,350	28.57 %	2 984 $
Charles Strogen 23.81 %	1,125	23.81 %	2 486 $
Francis Howard 19.05 %	900	19.05 %	1 989 $
Douglas R Armstrong 9.524 %	450	9.524 %	995 $

Name	Equities	%	Valuation
Chai Lifeline, Inc. 100.00 %	834	100.00 %	1 843 $

Dominari Holdings, Inc.

725 5th Avenue 23rd floor

10022, New York

+212-393-4540

http://www.aikidopharma.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+46.03%	55.66B
IQVIA HOLDINGS INC.	-7.53%	38.98B
LONZA GROUP AG	+36.02%	38.8B
CELLTRION, INC.	-9.38%	27.32B
ICON PUBLIC LIMITED COMPANY	+12.31%	26.29B
ALNYLAM PHARMACEUTICALS, INC.	-16.38%	20.25B
UNITED THERAPEUTICS CORPORATION	+30.79%	12.76B
MEDPACE HOLDINGS, INC.	+28.57%	12.18B
BIO-TECHNE CORPORATION	-0.36%	12.12B

Other Biotechnology & Medical Research